Company Encyclopedia
View More
name
SWK
SWKH.US
SWK Holdings Corporation is a venture debt firm specializing in early stage, seed/startup, series-A to series-D and growth capital investments. It seeks to invest in healthcare sectors including biopharma, medical devices, diagnostics, life science tools, selective healthcare service and HIT companies; technology; software; SaaS; and green energy/sustainability. It seeks to make investments between $5 million and $20 million, it may also invest higher. SWK Holdings Corporation was incorporated in 1996 and is headquartered in Dallas, Texas.
8.934 B
SWKH.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
Specialized FinanceIndustry
Industry Ranking2/15
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE8.45%B
    • Profit Margin56.61%A
    • Gross Margin98.62%A
  • Growth ScoreB
    • Revenue YoY62.38%A
    • Net Profit YoY117.28%A
    • Total Assets YoY-9.93%E
    • Net Assets YoY-10.31%D
  • Cash ScoreB
    • Cash Flow Margin176.66%C
    • OCF YoY62.38%A
  • Operating ScoreE
    • Turnover0.13E
  • Debt ScoreA
    • Gearing Ratio12.15%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Runway Growth Finance Receives Early FTC Clearance for SWK Holdings Merger

    Runway Growth Finance Corporation has received early termination of the waiting period from the U.S. Federal Trade Commission for its proposed merger with SWK Holdings Corporation. This satisfies one condition for the merger, which still requires SWK stockholder approval and other customary conditions. The original content was published via EDGAR by Runway Growth Finance Corporation.

    Reuters·
    US
    SWKH
    -3.44%
    US
    RWAY
    -0.54%
    Reuters·
    US
    SWKH
    -3.44%
    US
    RWAY
    -0.54%

    SWK (NASDAQ:SWKH) Stock Price Up 0.9% - Here's Why

    SWK Holdings Corp. (NASDAQ:SWKH) stock price increased by 0.9% during mid-day trading, reaching $16.9650. The trading volume was significantly lower than average. Analysts have downgraded the stock to a 'hold' rating, with an average target price of $18.00. The company reported strong quarterly earnings, surpassing estimates with $0.59 EPS. Institutional investors have been actively trading SWK shares, with significant increases in holdings by several firms. SWK Holdings provides finance and asset management services, focusing on life science companies.

    Market Beat·
    US
    SWKH
    -3.44%
    Market Beat·
    US
    SWKH
    -3.44%

    SWK | 10-Q: FY2025 Q3 Revenue: USD 10.88 M

    LB filings·
    US
    SWKH
    -3.44%
    LB filings·
    US
    SWKH
    -3.44%

    SWK Holdings reports Q3 net income of $8.8 million on $10.9 million revenue

    SWK Holdings Corp. reported Q3 2025 GAAP net income of $8.8 million, up from $3.5 million in Q3 2024, with total revenue of $10.9 million, a 4.8% increase year-over-year. The company closed the sale of most assets at MOD3 Pharma and repurchased 88,000 shares for $1.3 million. SWK also entered a merger agreement with Runway Growth Finance Corp., expected to close in late Q4 2025 or Q1 2026. Non-GAAP tangible financing book value rose to $19.42, a 12.4% increase year-over-year.

    Reuters·
    US
    SWKH
    -3.44%
    Reuters·
    US
    SWKH
    -3.44%

    23:58 ET SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates SWKH, ETNB, BRNS, VRNT on Behalf of Shareholders

    Halper Sadeh LLC is investigating SWK Holdings Corporation, 89bio, Inc., Barinthus Biotherapeutics plc, and Verint Systems Inc. for potential violations of federal securities laws and breaches of fiduciary duties to shareholders. The investigations concern SWKH's sale to Runway Growth Finance Corp., ETNB's sale to Roche, BRNS's merger with Clywedog Therapeutics, and VRNT's sale to Thoma Bravo. Shareholders are encouraged to contact Halper Sadeh LLC for legal rights and options regarding these transactions.

    prnewswire·
    US
    ETNB
    0.00%
    US
    SWKH
    -3.44%
    US
    BRNS
    -2.57%
    prnewswire·
    US
    ETNB
    0.00%
    US
    SWKH
    -3.44%
    US
    BRNS
    -2.57%
    © 2025 Longbridge｜Disclaimer